NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
Back to search
Official data from USPTO
APROGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/13/2024
Trademark type
Word
Nice classes
5
Filing date
05/31/2022
Registration date
02/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
02/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
SEONGNAM-SI, GYEONGGI-DO,, KR
Examiner
WILSON, MARYNELLE WEST
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
APROGEN INC.
APROGEN INC.
Representatives
Hun Joon Kim LEX IP MEISTER, PLLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for immunomodulation; Pharmaceutical preparations for immune-enhancing; Pharmaceutical preparations for intestinal health and for the prevention and treatment of respiratory diseases; Pharmaceutical preparations for digestive diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for treating intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Vaccines; Colostral antibodies for medical purposes; Antibody therapeutic preparations for medical purposes for the treatment of cancer; Pharmaceutical preparationsantibody for the treatment of acute respiratory distress syndromeARDS; Anti-cancer preparations; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and compositions for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of auto-immune diseases
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2023
PUBO
PUBLISHED FOR OPPOSITION
11/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2023
ALIE
ASSIGNED TO LIE
09/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2023
GNRT
NON-FINAL ACTION E-MAILED
03/21/2023
CNRT
NON-FINAL ACTION WRITTEN
03/21/2023
DOCK
ASSIGNED TO EXAMINER
03/16/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2022
NWAP
NEW APPLICATION ENTERED
06/03/2022
Continuous trademark protection
Get notified about every new filing that threatens APROGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.